Logo

FDC Limited Share Price

₹ 433.80
-₹0.45 (-0.1%)
1D
Last updated 03 Jul, 2026, 15:56 IST

FDC Limited Share Price Today

As of 5 Jul 2026, FDC Limited share price is ₹433.80. The stock opened at ₹434.50, compared to its previous close of ₹434.25. During today's trading session, FDC Limited share price moved in the range of ₹427.20 to ₹437.00, with an average price of ₹432.10 for the day. Looking at its last 52-week, the stock has touched a low of ₹312.95 and a high of ₹527.80. On the performance front, FDC Limited share price has increased by 3.40% over the last six months and is down 11.07% on a year-on-year basis.


₹427.20
0.10% down today
₹437.00
1D LOW
1D HIGH

FDC Limited Returns Calculator

Open
₹434.50
High
₹437.00
Low
₹427.20
Prev. close
₹434.25

Circuit
L
H
₹347.05
₹520.55
52-week
L
H
₹312.95
₹527.80

FDC Limited Shareholder Returns

FDC Limited Share Price History

Mkt Cap Cr
7,067.59

P/E
25.11

P/B
2.84

ROE
11.32%

D/E
0.01

ROCE
15.18%

Div. Yield
1.15%

EPS(TTM)
17.56
Turnover
0.83

EV/EBITDA
15.90

Net Margin
0.00%

Op. Margin
0.00%

ROA
9.64%

Quick Ratio
0.00

Curr. Ratio
3.18
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
FDC outperforming all market indices
Step 3 of 5
Valuation
Fairly Valued
FDC appears to be fairly valued compared to its peers
Step 5 of 5
Earnings
Excellent
FDC revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,49,048.0039.025.3713.74%0.6117.33%93.240.85%0.5610.90
Divis Laboratories1,77,179.0069.0010.5715.32%0.0019.56%629.490.45%0.5898.19
Torrent Pharmaceuticals1,57,804.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,17,642.0025.472.8711.79%0.0015.66%2.891.06%0.4943.52
Dr. Reddy's Laboratories1,12,368.0027.032.9711.07%0.1812.54%375.780.59%0.6338.68
Zydus Lifesciences1,10,651.0021.604.0818.59%0.3117.35%235.250.09%0.3935.38
Lupin1,09,676.0020.484.8923.76%0.0424.88%659.050.75%0.61129.18
Mankind Pharma1,02,729.0053.006.3011.74%0.3413.13%397.020.04%0.5449.37
Aurobindo Pharma90,608.0025.872.399.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs82,398.9060.2610.1018.21%0.4516.70%10.190.20%0.9713.72

FDC Limited Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹2,108.12₹1,942.94₹1,783.75₹1,527.92
Other Income₹90.66₹101.63₹49.86₹76.09
Total Revenue₹2,198.78₹2,044.58₹1,833.61₹1,604.01
Total Expenses₹1,841.56₹1,648.36₹1,575.80₹1,314.62
Profit Before Tax₹357.22₹396.22₹257.80₹289.39
Tax₹90.43₹91.16₹63.98₹73.23
Profit After Tax₹266.79₹305.06₹193.83₹216.16
EPS - Basic₹16.39₹18.58₹11.66₹12.81
EPS - Diluted₹16.39₹18.58₹11.66₹12.81

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹357.22₹396.22₹257.80₹289.39
Income before WC changes₹332.44₹345.04₹262.12₹262.91
Change in Assets₹40.70-₹39.06-₹86.03-₹91.71
Change in Liabilities₹47.23₹18.71₹56.13₹69.98
Change in WC₹87.94-₹20.35-₹29.91-₹21.72
Cash flow from Operations₹317.57₹220.77₹154.91₹161.65
Cash flow from Investing-₹199.51-₹17.08₹11.13-₹144.57
Cash flow from Financing-₹92.12-₹202.16-₹179.95-₹9.84
Total Cash Flow₹25.94₹1.53-₹13.90₹7.25
Cash (Start of the year)₹25.42₹23.89₹37.73₹30.43
Cash (End of the year)₹51.47₹25.42₹23.89₹37.73

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹1,625.09₹1,401.60₹1,317.88₹1,270.02
Current Assets₹1,088.72₹1,066.49₹1,025.06₹1,000.19
Total Assets₹2,713.80₹2,468.09₹2,342.94₹2,270.20
Current Liabilities₹361.64₹310.62₹311.56₹272.16
Net Current Asset₹727.08₹755.87₹713.50₹728.03
Non-Current Liabilities₹71.08₹60.30₹49.98₹41.69
Equity Capital₹2,281.08₹2,097.17₹1,981.40₹1,956.36
Total Equity & Liabilities₹2,713.80₹2,468.09₹2,342.94₹2,270.20

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹2,070.11₹1,916.19₹1,777.03₹1,518.97
Other Income₹105.52₹103.22₹53.91₹78.73
Total Revenue₹2,175.63₹2,019.40₹1,830.94₹1,597.70
Total Expenses₹1,807.96₹1,621.46₹1,565.25₹1,312.25
Profit Before Tax₹367.67₹397.95₹265.69₹285.45
Tax₹94.05₹90.78₹64.72₹65.82
Profit After Tax₹273.63₹307.16₹200.97₹219.64
EPS - Basic₹16.81₹18.70₹12.09₹13.01
EPS - Diluted₹16.81₹18.70₹12.09₹13.01

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹367.67₹397.95₹265.69₹285.45
Income before WC changes₹327.76₹345.62₹266.69₹261.86
Change in Assets₹42.19-₹38.27-₹81.61-₹91.21
Change in Liabilities₹43.21₹16.36₹56.50₹70.04
Change in WC₹85.40-₹21.91-₹25.11-₹21.17
Cash flow from Operations₹310.34₹220.81₹164.72₹162.38
Cash flow from Investing-₹199.45-₹17.76₹3.62-₹147.42
Cash flow from Financing-₹92.10-₹202.03-₹179.83-₹9.70
Total Cash Flow₹18.79₹1.02-₹11.49₹5.26
Cash (Start of the year)₹20.77₹19.75₹31.13₹25.72
Cash (End of the year)₹39.67₹20.77₹19.75₹31.13

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹1,642.26₹1,404.06₹1,311.66₹1,265.67
Current Assets₹1,068.06₹1,054.57₹1,023.76₹988.58
Total Assets₹2,710.32₹2,458.63₹2,335.42₹2,254.25
Current Liabilities₹355.01₹307.67₹310.69₹270.62
Net Current Asset₹713.05₹746.90₹713.07₹717.96
Non-Current Liabilities₹68.12₹53.76₹43.99₹34.94
Equity Capital₹2,287.19₹2,097.20₹1,980.74₹1,948.69
Total Equity & Liabilities₹2,710.32₹2,458.63₹2,335.42₹2,254.25
* All values are in INR Crore
Qty
Bid
30100
433.8
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 30100
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
4
Neutral
2
Bullish
2
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict

RSI (14)
70.46
Bullish

ATR (14)
12.82
Neutral

STOCH(9,6)
93.58
Bearish

STOCH RSI (14)
98.25
Bearish

ADX(9)
51.14
Bearish

UO(9)
54.33
Neutral

ROC(12)
12.9
Bullish

WillR(14)
-5.61
Bearish
Period
Simple value
Exponential vaue

5D
428.63
427.71

10D
416.71
418.48

20D
400.22
407.04

50D
386.16
390.76

100D
372.45
385.77

About FDC Limited

FDC Limited logo
ISIN
INE258B01022
Sector Market Cap
₹ 7,067.59 Cr

FDC Limited is an India-based company, which is principally engaged in the business of manufacturing and trading of pharmaceutical products. The Company is specialized in manufacturing Oral Rehydration Solutions (ORS), energy drinks, antibiotics and ophthalmic therapies. Its products include Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen Sodium, Miconazole Nitrate, Timolol Maleate, Amoxycillin + Clavulanic Acid, Rupatadine Fumarate, Salbutamol Sulphate, Kaolin Light/ Pectin, among others. The Company’s product offerings cover an extensive range of categories, including anti-infectives, gastrointestinal treatments, ophthalmic, vitamins, minerals, dietary supplements, cardiovascular solutions, anti-diabetics, respiratory care, gynecology, dermatology and analgesics. Its various brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.

FDC Limited Financial Highlights

  • Revenue: FDC Limited reported revenue of ₹2,284.45 crore in FY26 vs ₹2,198.78 crore in FY25. It showed an increase of 3.90% on a yearly basis.
  • Operating Profit: FDC Limited reported an operating profit of ₹374.60 crore in FY26 vs ₹357.22 crore in FY25. It showed an increase of 4.87% on a year-on-year basis.
  • Net Profit: FDC Limited reported a net profit of ₹281.42 crore in FY26 vs ₹266.79 crore in FY25. It showed an increase of 5.48% on a yearly basis.

FDC Limited Quarterly Result Highlights

  • FDC Limited reported revenue of ₹634.68 crore in Mar 2026, compared with ₹485.51 crore in Dec 2025, representing an increase of 30.72% on a quarter-on-quarter (QoQ) basis.
  • FDC Limited reported an operating profit of ₹140.35 crore in Mar 2026, compared with ₹36.38 crore in Dec 2025, representing an increase of 285.79% on a quarter-on-quarter (QoQ) basis.
  • FDC Limited reported a profit of ₹103.40 crore in Mar 2026, compared with ₹28.30 crore in Dec 2025, reflecting an increase of 265.37% on a QoQ basis.
  • The earnings per share (EPS) of FDC Limited stood at ₹16.39 during Mar 2026.
Know more
Promoters
69.66%
FII
2.40%
Other DII
0.06%
Retail and other
21.65%
Mutual funds
6.23%
Foreign institutions - FII
Compare against other stocks
FDC Limited logo
FDC Limited
Pharmaceuticals
Add Stock
Add Another

FAQs on FDC Limited Share Price